TUSTIN, Calif. (AP) _ Peregrine Pharmaceuticals Inc. (PPHM) on Monday reported a loss of $7.8 million in its fiscal third quarter.
On a per-share basis, the Tustin, California-based company said it had a loss of 4 cents.
The pharmaceutical posted revenue of $10.7 million in the period.
Peregrine expects full-year revenue in the range of $60 million to $65 million.
In the final minutes of trading on Monday, the company's shares hit 76 cents. A year ago, they were trading at 41 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PPHM at https://www.zacks.com/ap/PPHM
Keywords: Peregrine, Earnings Report